Not Tagged
Precigen therapeutics
['$pgen']
#asco23: #precigen announces positive phase 1 data for prgn-2009 adenoverse immunotherapy alone and in combination with an investigational checkpoint inhibitor in patients with r/m hpv-associated cancers. view press release: #oncology #oncoalert $pgen 
Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies.